| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.37 | 0.07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.07 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.08 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.12 | 0.08 |